Csk-binding protein can regulate Lyn signals controlling cell morphology

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 6, 2009, Pages 1332-1343

  Ingley, Evan ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cbp; Lyn; PAG; Src family kinase; Tyrosine kinase

Indexed keywords

BINDING PROTEIN; C TERMINAL SRC KINASE BINDING PROTEIN; MUTANT PROTEIN; PROTEIN KINASE LYN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL INTERACTION; CELL STRUCTURE; ERYTHROID CELL; FILOPODIUM; LAMELLIPODIUM; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL SHAPE; CERCOPITHECUS AETHIOPS; COS CELLS; DOWN-REGULATION; ERYTHROID CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; JANUS KINASE 2; MEMBRANE PROTEINS; MICE; PHOSPHOPROTEINS; PHOSPHORYLATION; SRC-FAMILY KINASES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 60649085974     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.12.001     Document Type: Article

References (45)

1. Bao H.F., Jacobs-Helber S.M., Lawson A.E., Penta K., Wickrema A., and Sawyer S.T. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 93 (1999) 3757-3773
2. Bouscary D., Pene F., Claessens Y.-E., Muller O., Chrétien S., Fontenay-Roupie M., et al. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood 101 (2003) 3436-3443
3. Brdicka T., Pavlistova D., Leo A., Bruyns E., Korinek V., Angelisova P., et al. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation. J Exp Med 191 (2000) 1591-1604
4. Brdickova N., Brdicka T., Andera L., Spicka J., Angelisova P., Milgram S.L., et al. Interaction between two adapter proteins PAG and EBP50: a possible link between membrane rafts and actin cytoskeleton. FEBS Lett 507 (2001) 133-136
5. Brunati A.M., Bordin L., Clari G., James P., Quadroni M., Baritono E., et al. Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites. Blood 96 (2000) 1550-1557
6. Chin H., Arai A., Wakao H., Kamiyama R., Miyasaka N., and Miura O. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood 91 (1998) 3734-3745
7. Corey S.J., and Anderson S.M. Src-related protein tyrosine kinases in hematopoiesis. Blood 93 (1999) 1-14
8. Crouin C., Arnaud M.L., Gesbert F., Camonis J., and Bertoglio J. A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners. FEBS Lett 495 (2001) 148-153
9. Damen J.E., Wakao H., Miyajima A., Krosl J., and Humphries R.K. Cutler RL and Krystal G Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J 14 (1995) 5557-5568
10. Davidson D., Bakinowski M., Thomas M.L., Horejsi V., and Veillette A. Phosphorylation-dependent regulation of T-cell activation by PAG/Cbp, a lipid raft-associated transmembrane adaptor. Mol Cell Biol 23 (2003) 2017-2028
11. Gouilleux F., Pollard C., Dusanter-Fourt I., Wakao H., Haldosen L.-A., Norstedt G., et al. Prolactin, growth hormone, erythropoietin and granulocyte-colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J 14 (1995) 2005-2013
12. Gregoli P.A., and Bondurant M.C. The roles of Bcl-XL and apopain in the control of erythropoiesis by erythropoietin. Blood 90 (1997) 630-640
13. Harder K.W., Quilici C., Naik E., Inglese M., Kountouri N., Turner A., et al. Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. Blood 104 (2004) 3901-3910
14. Hawley R.G., Lieu F.H.L., Fong A.Z.C., and Hawley T.S. Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1 (1994) 136-138
15. Hibbs M.L., Tarlinton D.M., Armes J., Grail D., Hodgson G., Maglitto R., et al. Multiple defects in the immune system of lyn-deficient mice, culminating in autoimmune disease. Cell 83 (1995) 301-311
16. Ingley E., Williams J.H., Walker C.E., Tsai S., Colley S., Sayer M.S., et al. A novel ADP-ribosylation like factor (ARL-6), interacts with the protein-conducting channel SEC61beta subunit. FEBS Lett 459 (1999) 69-74
17. Ingley E., Sarna M.K., Beaumont J.G., Tilbrook P.A., Tsai S., Takemoto Y., et al. HS1 interacts with Lyn and is critical for erythropoietin-induced differentiation of erythroid cells. J Biol Chem 275 (2000) 7887-7893
18. Ingley E., Chappell D., Poon S.Y., Sarna M.K., Beaumont J.G., Williams J.H., et al. Thyroid hormone receptor-interacting protein 1 modulates cytokine and nuclear hormone signaling in erythroid cells. J Biol Chem 276 (2001) 43428-43434
19. Ingley E., McCarthy D.J., Pore J.R., Sarna M.K., Adenan A.S., Wright M.J., et al. Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis. Oncogene 24 (2005) 336-343
20. Ingley E., Schneider J.R., Payne C.J., McCarthy D.J., Harder K.W., Hibbs M.L., et al. Csk-binding protein mediates sequential enzymatic down-regulation and degradation of Lyn in erythropoietin-stimulated cells. J Biol Chem 281 (2006) 31920-31929
21. Ingley E. Src family kinases: regulation of their activities, levels and identification of new pathways. Biochimica et Biophysica Acta 1784 (2008) 56-65
22. Karur V.G., Lowell C.A., Besmer P., Agosti V., and Wojchowski D.M. Lyn kinase promotes erythroblast expansion and late-stage development. Blood 108 (2006) 1524-1532
23. Kasahara K., Nakayama Y., Sato I., Ikeda K., Hoshino M., Endo T., et al. Role of Src-family kinases in formation and trafficking of macropinosomes. J Cell Physiol 211 (2007) 220-232
24. Kawabuchi M., Satomi Y., Takao T., Shimonishi Y., Nada S., Nagai K., et al. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 404 (2000) 999-1003
25. Klinken S.P., Nicola N.A., and Johnson G.R. "In vitro"-derived leukemic cell lines induced by a raf- and myc-containing retrovirus differentiate in response to erythropoietin. Proc Natl Acad Sci USA 85 (1988) 8506-8510
26. Lecoq-Lafon C., Verdier F., Fichelson S., Chretien S., Gisselbrecht S., Lacombe C., et al. Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase. Blood 93 (1999) 2578-2585
27. Lowell C.A. Src-family kinases: rheostats of immune cell signaling. Mol Immunol 41 (2004) 631-643
28. Manes G., Bello P., and Roche S. Slap negatively regulates Src mitogenic function but does not revert Src-induced cell morphology changes. Mol Cell Biol 20 (2000) 3396-3406
29. Miura Y., Miura O., Ihle J.N., and Aoki N. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem 269 (1994) 29962-29969
30. Rhodes M.M., Kopsombut P., Bondurant M.C., Price J.O., and Koury M.J. Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin. Blood 111 (2008) 1700-1708
31. Robles E., Woo S., and Gomez T.M. Src-dependent tyrosine phosphorylation at the tips of growth cone filopodia promotes extension. J Neurosci 25 (2005) 7669-7681
32. Sadahira Y., and Mori M. Role of the macrophage in erythropoiesis. Pathol Int 49 (1999) 841-848
33. Smida M., Posevitz-Fejfar A., Horejsi V., Schraven B., and Lindquist J.A. A novel negative regulatory function of the phosphoprotein associated with glycosphingolipid-enriched microdomains: blocking Ras activation. Blood 110 (2007) 596-615
34. Tauzin S., Ding H., Khatib K., Ahmad I., Burdevet D., van Echten-Deckert G., et al. Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts. Blood 111 (2008) 2310-2320
35. Tilbrook P.A., Bittorf T., Busfield S.J., Chappell D., and Klinken S.P. Disrupted signaling in a mutant J2E cell line that shows enhanced viability, but does not proliferate or differentiate, with erythropoietin. J Biol Chem 271 (1996) 3453-3459
36. Tilbrook P.A., Ingley E., Williams J.H., Hibbs M.L., and Klinken S.P. Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells. EMBO J 16 (1997) 1610-1619
37. Tilbrook P.A., Palmer G.A., Bittorf T., McCarthy D.J., Wright M.J., Sarna M.K., et al. Maturation of erythroid cells and erythroleumkemia development are affected by the kinase activity of Lyn. Cancer Res 61 (2001) 2453-2458
38. Timpson P., Jones G.E., Frame M.C., and Brunton V.G. Coordination of cell polarization and migration by the Rho family GTPases requires Src tyrosine kinase activity. Curr Biol 11 (2001) 1836-1846
39. Veracini L., Simon V., Richard V., Schraven B., Horejsi V., Roche S., et al. The Csk-binding protein PAG regulates PDGF-induced Src mitogenic signaling via GM1. J Cell Biol 182 (2008) 603-614
40. Vielreicher M., Harms G., Butt E., Walter U., and Obergfell A. Dynamic interaction between Src and C-terminal Src kinase in integrin alphaIIbbeta3-mediated signaling to the cytoskeleton. J Biol Chem 282 (2007) 33623-33631
41. Vojtek A.B., Hollenberg S.M., and Cooper J.A. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74 (1993) 205-214
42. Watowich S.S., Yoshimura A., Longmore G.D., Hilton D.J., Yoshimura Y., Lodish H.F., et al. constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci USA 89 (1992) 2140-2144
43. Williams J.H., Daly L.N., Ingley E., Beaumont J.G., Tilbrook P.A., Lalonde J.P., et al. HLS7, a hemopoietic lineage switch gene homologous to the leukemia-inducing gene MLF1. EMBO J 18 (1999) 5559-5566
44. Witthuhn B., Quelle F., Silvennoinen O., Yi T., Tang B., Miura O., et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74 (1993) 227-236
45. Zhang S.Q., Yang W.T., Kontaridis M.I., Bivona T.G., Wen G.Y., Araki T., et al. Shp2 regulates Src family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell 13 (2004) 341-355